{
    "code": "52027857",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027857",
    "time": "2021-06-18 03:18:54",
    "許可證字號": "衛部藥輸字第027857號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/05\/21",
    "發證日期": "109\/05\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202785703",
    "中文品名": "施覓福膜衣錠100毫克",
    "英文品名": "Smyraf film-coated Tablets 100mg",
    "適應症": "合併methotrexate或其他傳統型疾病緩解型抗風濕藥物(DMARDs)，適用於治療患有中度至重度活動性類風濕性關節炎，且對至少一種傳統型疾病緩解型抗風濕藥物(DMARDs)無法產生適當治療反應或無法耐受之成人病人。\r\n與methotrexate併用，經X光檢查顯示可減緩疾病造成的關節結構性受損。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/05\/21",
    "主成分略述": "Peficitinib Hydrobromide",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5E已執行國內臨床試驗",
    "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
    "申請商地址": "台北市中山區民生東路３段１０號５樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0401100  ASTELLAS PHARMA TECH CO., LTD. YAIZU TECHNOLOGY CENTER",
            "製造廠廠址": "180 OZUMI, YAIZU-SHI, SHIZUOKA 425-0072  JAPAN",
            "製造廠公司地址": "5-1, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200060000",
            "成分名稱": "Peficitinib Hydrobromide",
            "含量描述": "(Equal to Peficitinib......100MG)",
            "含量": "124.8000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "smyraf 50、100mg 仿單-109-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027857&Seq=001&Type=9"
        },
        {
            "title": "smyraf 100mg 外盒鋁箔-109-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027857&Seq=001&Type=8"
        }
    ]
}